Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Epigenetics and Nuclear Signaling DNA / RNA RNA Processing RNAi

Human DROSHA knockout HEK-293T cell lysate (ab257171)

Price and availability

331 689 ₸

Availability

Order now and get it on Wednesday March 03, 2021

Human DROSHA knockout HEK-293T cell lysate (ab257171)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

You may also be interested in

Product image
Recombinant Human PIWIL1 protein (ab152968)
Product image
Anti-Dicer antibody [EPR24104-105] (ab259327)
Product image
Anti-PIWIL4/PIWI antibody (ab111714)
Product image
Anti-DGCR8 antibody (ab90579)

Properties

  • Storage instructions

    Store at -80°C. Please refer to protocols.
  • Components 1 kit
    ab260929 - Human DROSHA knockout HEK293T cell lysate 1 x 100µg
    ab255553 - Human wild-type HEK293T cell lysate 1 x 100µg
  • Research areas

    • Epigenetics and Nuclear Signaling
    • DNA / RNA
    • RNA Processing
    • RNAi
    • Epigenetics and Nuclear Signaling
    • RNAi
    • Dicer
    • Epigenetics and Nuclear Signaling
    • Nuclear Signaling Pathways
    • Nuclear Receptors
    • Nuclear Pore Complex
  • Cell type

    epithelial
  • STR Analysis

    Amelogenin X D5S818: 8, 9 D13S317: 12, 14 D7S820: 11 D16S539: 9, 13 vWA: 16, 19 TH01: 7, 9.3 TPOX: 11 CSF1PO: 11, 12

Images

  • Western blot - Human DROSHA knockout HEK293T cell lysate (ab257171)
    Western blot - Human DROSHA knockout HEK293T cell lysate (ab257171)

    Lane 1: Wild-type HEK293T cell lysate (20 µg)

    Lane 2: DROSHA knockout HEK293T cell lysate (20 µg)

    Lane 3: HeLa cell lysate (20 µg)

    Lanes 1-3: Merged signal (red and green). Green - ab183732 observed at 159 kDa. Red - loading control, ab8245 observed at 37 kDa.

    ab183732 Anti-Drosha antibody [EPR12794] was shown to specifically react with Drosha in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266217 (knockout cell lysate ab257171) was used. Wild-type and Drosha knockout samples were subjected to SDS-PAGE. ab183732 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.

  • Sanger Sequencing - Human DROSHA knockout HEK293T cell lysate (ab257171)
    Sanger Sequencing - Human DROSHA knockout HEK293T cell lysate (ab257171)
    Homozygous: 1 bp insertion in exon 4

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-TLR7 antibody [4F4] (ab28048)

  •  
  • Product image

    Anti-ESE1 antibody (ab275592)

  •  
  • Product image

    Anti-EZH1 antibody (ab263961)

  •  
  • Product image

    Anti-KSR2 antibody (ab173377)

  •  
  • Product image

    Recombinant Human N Cadherin protein (ab112268)

  •  
  • Product image

    NS 398, COX-2 inhibitor (ab120295)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.